Humabs BioMed, a subsidiary of Vir Biotechnology, uses its immunologic expertise and cutting-edge technology to combat infectious diseases and other serious conditions. They are a pioneer in the discovery, engineering, and development of human monoclonal antibodies.
- http://www.vir.bio
- +41 91 825 63 80
- info@humabs.ch
- Filippo Riva
